找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Needs and Feasibility; A Guide for Engineer Caroline Baillie,Eric Feinblatt,Emily Berrington Book 2010 Springer Nature Switzerland AG 2010

[复制链接]
楼主: FAD
发表于 2025-3-25 05:51:01 | 显示全部楼层
Caroline Baillie,Eric Feinblatt,Thimothy Thamae,Emily Berringtonng β2 agonists, which are effective in the majority of patients with asthma. However, therapeutic responses to these agents vary. Severe asthma is characterized by uncontrolled symptoms and recurrent exacerbation with excessive chronic airway inflammation despite adequate and even maximum treatment
发表于 2025-3-25 10:59:38 | 显示全部楼层
Caroline Baillie,Eric Feinblatt,Thimothy Thamae,Emily Berringtonion of severe asthma, predict efficacy of specific therapies, and assess medication response. Pulmonary function testing is an essential biomarker for the diagnosis and management of asthma. Recently, spirometric parameters reflecting small-airway obstruction have shown promise in the diagnosis and
发表于 2025-3-25 13:15:20 | 显示全部楼层
Caroline Baillie,Eric Feinblatt,Thimothy Thamae,Emily Berringtonular, cellular, morphological, functional, and clinical features. This concept of the disease is particularly important for severe asthma, which is also extremely heterogeneous and accounts for a significant proportion of health-care expenditure of asthma, because it may enable us to develop safe an
发表于 2025-3-25 17:22:04 | 显示全部楼层
发表于 2025-3-25 23:18:07 | 显示全部楼层
Caroline Baillie,Eric Feinblatt,Thimothy Thamae,Emily Berringtonng β2 agonists, which are effective in the majority of patients with asthma. However, therapeutic responses to these agents vary. Severe asthma is characterized by uncontrolled symptoms and recurrent exacerbation with excessive chronic airway inflammation despite adequate and even maximum treatment
发表于 2025-3-26 02:39:12 | 显示全部楼层
发表于 2025-3-26 04:18:01 | 显示全部楼层
es, and the mainstay of therapy for this population remains inhaled corticosteroids with the addition of another controller medication. The preferred additional controller medication in older (school-age) children and adolescents is long-acting beta-agonist (LABA) delivered in a combination device,
发表于 2025-3-26 11:47:00 | 显示全部楼层
发表于 2025-3-26 13:52:00 | 显示全部楼层
Assessing the Need in Lesotho,facilitated by Waste for Life. We selected to work in Lesotho because the key researcher in our laboratory at Queens in Canada was from there (Thimothy Thamae), and he suggested that the materials and process would be very beneficial for his country. Before embarking on such a project we knew we had
发表于 2025-3-26 17:29:45 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-25 03:40
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表